Singapore: Symphogen signed an exclusive worldwide license agreement with Merck in Germany for Sym004, an investigationa...
Singapore: US-based Kinex Pharmaceuticals's application for the Small Entrepreneur Research Assistance Programme has bee...
Singapore: Influenza vaccine (gH1-Qbeta) developed by Singapore's Agency for Science, Technology and Research (A*STAR) a...
Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years...
Singapore: Cancer treatments are becoming increasingly personalized, as regulators are approving therapeutics offering s...
Singapore: GlaxoSmithKline (GSK) and Theravance submitted a regulatory application in the European Union for the investi...
Singapore: In an effort to explore biological influences on the varying appearance of autism spectrum disorder (ASD), Dr...
‎Singapore: Australia-based CSL Behring achieved improved pharmacokinetic results for its novel investigational re...
Singapore: Sanofi and US-based Transgene have launched the construction phase of the manufacturing platform dedicated to...
Singapore: Allied Healthcare has achieved positive results in the study of Adapt-treated tissue as a bioprosthetic subst...
Singapore: Australia based Biotron's HIV drug candidate BIT225 has demonstrated its ability to reverse HIV-induced impai...
Singapore: A research team from Case Western Reserve University School of Medicine has discovered an approach that could...
Singapore: Drug development company Charles River Laboratories has marked net sales of $292.9 million in the second quar...
‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0...
Singapore: A phase III study conducted at the Cincinnati Children's Hospital Medical Center, US, has revealed that pati...
Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deut...
Singapore: Researchers at University of California have found that prenatal exposure to specific combinations of antibod...
Singapore: Europe's CellSeed has withdrawn its application for a centralized marketing authorization for the medicine Or...
